CFCorinne Fouveaut

Corinne Fouveaut

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Corinne Fouveaut has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Aude Brac de la Perrière

    Service d’Endocrinologie, de Diabétologie Et Des Maladies Métaboliques A, Hospices Civiles de Lyon, Lyon, France

    1 shared publication
  • Camille Verebi

    Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Equipe Gorwood/Ramoz Paris France

    1 shared publication
  • Geneviève Plu-Bureau

    Gynecological Unit Cochin-Port-Royal Hospital University Paris Cité, Paris, France; Faculty of medicine, Université Paris Cité, Paris, France; Women's Cardiovascular Health care Foundation 22 rue de Londres, 75009, Paris, France; Inserm 1153 Team OPPaLE Port-Royal Hospital Paris, France

    1 shared publication
  • Jean-Michel Dupont

    Service de Médecine Génomique des Maladies de Système et d'Organe, Hôpital Cochin AP-HP.Centre - Université de Paris, Paris, France

    1 shared publication
  • Laila El Khattabi

    Service de Médecine Génomique Des Maladies de Système Et d’Organe, Hôpital Cochin, APHP, Centre Université de Paris Cité, Paris, France

    1 shared publication
  • Philippe Touraine

    Département d’Endocrinologie Et Médecine de La Reproduction, APHP. Sorbonne Université, Pitié-Salpêtrière Hospital, Center for Rare Endocrine and Gynecological Disorders, ERN-HCP, Paris, France

    1 shared publication

Latest Publications

  • NOBOX gene variants in premature ovarian insufficiency: ethnicity-dependent insights

    by Pénélope Jordan, Camille Verebi, Sandrine Perol, Sarah Grotto, Corinne Fouveaut, Sophie Christin-Maitre, Aude Brac de la Perrière, Virginie Grouthier, Sophie Jonard-Catteau, Philippe Touraine, et al.

    Purpose Premature ovarian insufficiency (POI) affects approximately 1% of women before the age of 40. Genetic contribution is a significant component of POI. The NOBOX gene was considered one of the major genetic causes of POI. However, the pathogenicity and the penetrance of NOBOX variants remain unclear. Methods We studied the whole coding region of the NOBOX gene by next generation sequencing in a cohort of 810 patients with POI, and we compared the frequency of each identified NOBOX variant to the general population taking into account the ethnicity of each individual. Results Screening of the whole coding region of the NOBOX gene allowed us to identify 35 different variants, including 5 loss-of-function variants. In total, 171 patients with POI (25%) carried out at least one NOBOX variant. Regarding missense variants, we observed a significant overrepresentation of the most frequent ones in our 810 POI patients as compared to the general, except for p.(Arg117Trp). However, taking into account the ethnic origin of the individuals, we observed no significant OR difference for p.(Arg44Leu) and p.(Arg117Trp) in African subgroup and for p.(Asp452Asn) in European subgroup. Conclusion This population study suggests that the p.(Arg44Leu) variant could be considered benign variant and that the p.(Asp452Asn) and p.(Arg117Trp) variants could be considered moderate risk pathogenic variants with probably partial and very low penetrance and/or expressivity. In contrast, p.(Gly91Trp) and p.(Gly152Arg) variants could be considered pathogenic variants with a moderate functional impact.